Wespiser M, Neidhardt E, Negrier S. Uveal melanoma: in the era of new treatments. Cancer Treat Rev. 2023;119:102599.
Article CAS PubMed Google Scholar
Fallico M, Raciti G, Longo A, Reibaldi M, Bonfiglio V, Russo A, et al. Current molecular and clinical insights into uveal melanoma (Review). Int J Oncol. 2021;58:10.
Manchegowda P, Singh AD, Shields C, Kaliki S, Shah P, Gopal L, et al. Uveal melanoma in Asians: a review. Ocul Oncol Pathol. 2021;7:159–67.
Article PubMed PubMed Central Google Scholar
Zhou C, Wang Y, Jia R, Fan X. Conjunctival melanoma in chinese patients: local recurrence, metastasis, mortality, and comparisons with caucasian patients. Investig Ophthamol Vis Sci. 2017;58:5452–9.
Buonanno F, Conson M, de Almeida Ribeiro C, Oliviero C, Itta F, Liuzzi R, et al. Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: a systematic review and a data pooled analysis. Radiother Oncol. 2022;166:15–25.
Kaštelan S, Mrazovac Zimak D, Ivanković M, Marković I, Gverović Antunica A. Liver metastasis in uveal melanoma - treatment options and clinical outcome. Front Biosci. 2022;27:72.
Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115:1778–85.
Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–93.
Kilby W, Dooley J, Kuduvalli G, Sayeh S, Maurer CR Jr. The CyberKnife® robotic radiosurgery system in 2010. Technol Cancer Res Treat. 2010;9:433–52.
Reichstein DA, Brock AL. Radiation therapy for uveal melanoma: a review of treatment methods available in 2021. Curr Opin Ophthalmol. 2021;32:183–90.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Cai S, Zhou J, Pan J. Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis. Stat Methods Med Res. 2021;30:2701–19.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Article CAS PubMed PubMed Central Google Scholar
Eibl-Lindner K, Fuerweger C, Nentwich M, Foerster P, Wowra B, Schaller U, et al. Robotic radiosurgery for the treatment of medium and large uveal melanoma. Melanoma Res. 2016;26:51–57.
Article CAS PubMed Google Scholar
Yazici G, Kiratli H, Ozyigit G, Sari SY, Cengiz M, Tarlan B, et al. Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma. Int J Radiat Oncol Biol Phys. 2017;98:152–8.
Liegl R, Schmelter V, Fuerweger C, Foerster MH, Muacevic A, Priglinger SG, et al. Robotic CyberKnife radiosurgery for ciliary body melanoma. Ophthalmol Retin. 2020;4:954–6.
Ozcan GC, Gunduz AK, Mirzayev I, Oysul K, Uysal H. Early results of stereotactic radiosurgery in uveal melanoma and risk factors for radiation retinopathy. Turkish J Ophthalmol. 2020;50:156–62.
Baskan C, Akkas EA, Gökce SE, Ozdogan S. Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma. Acta Oncol. 2022;61:1412–6.
Article CAS PubMed Google Scholar
Yazici G, Kiratli H, Ozyigit G, Sari SY, Elmali A, Yilmaz MT, et al. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity. Radiother Oncol. 2022;176:39–45.
Liegl R, Schmelter V, Fuerweger C, Ehret F, Priglinger S, Muacevic A, et al. Robotic CyberKnife radiosurgery for the treatment of choroidal and ciliary body. Am J Ophthalmol. 2023;250:177–85.
Schmelter V, Schneider F, Guenther SR, Fuerweger C, Muacevic A, Priglinger SG, et al. Local recurrence in choroidal melanomas following robotic assisted radiosurgery (CyberKnife). Ocul Oncol Pathol. 2023;8:221–9.
Choi SY, Kim M-S, Yoo SY, Cho CK, Lhee CH, Lee DH, et al. Feasibility of image-guided robotic radiotherapy using three fractions for uveal melanoma. Tumor J. 2009;95:720–5.
Siedlecki J, Reiterer V, Leicht S, Foerster P, Kortuem K, Schaller U, et al. Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy. Acta Ophthalmol. 2017;95:e734–9.
Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279–89.
Article CAS PubMed PubMed Central Google Scholar
Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol. 2017;101:38–44.
Schefler AC, Kim RS. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev. 2021;10:51.
Article CAS PubMed PubMed Central Google Scholar
Daftari IK, Petti PL, Shrieve DC, Phillips TL. Newer radiation modalities for choroidal tumors. Int Ophthalmol Clin. 2006;46:69–79.
Muacevic A, Nentwich M, Wowra B, Staerk S, Kampik A, Schaller U. Development of a streamlined, non-invasive robotic radiosurgery method for treatment of uveal melanoma. Technol Cancer Res Treat. 2008;7:369–74.
Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR Jr. The CyberKnife robotic radiosurgery system in 2010. Technol Cancer Res Treat. 2010;9:433–52.
Article CAS PubMed Google Scholar
Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013;27:163–71.
Article CAS PubMed Google Scholar
Guleser UY, Sarici AM, Ucar D, Gonen B, Sengul Samanci N, Özgüroğlu M. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients. Graefes Arch Clin Exp Ophthalmol. 2022;260:1337–43.
Article CAS PubMed Google Scholar
Desjardins L, Lumbroso-Le Rouic L, Levy-Gabriel C, Cassoux N, Dendale R, Mazal A, et al. Treatment of uveal melanoma by accelerated proton beam. Dev Ophthalmol. 2012;49:41–57.
Zemba M, Dumitrescu OM, Gheorghe AG, Radu M, Ionescu MA, Vatafu A, et al. Ocular complications of radiotherapy in uveal melanoma. Cancers. 2023;15:333.
Gollrad J, Böker A, Vitzthum S, Besserer A, Heufelder J, Gauger U, et al. Proton therapy for 166 patients with Iris melanoma: side effects and oncologic outcomes. Ophthalmol Retina. 2023;7:266–74.
Tran BK, Schalenbourg A, Bovey E, Zografos L, Wolfensberger TJ. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma. Retina. 2013;33:1777–83.
Summanen P, Immonen I, Kivelä T, Tommila P, Heikkonen J, Tarkkanen A. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol. 1996;80:732–9.
留言 (0)